Fusion Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Area bibliophiles on what they loved in 2023 and what to read in 2024 ideastream.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ideastream.org Daily Mail and Mail on Sunday newspapers.
By Ben Glickman Shares of Fusion Pharmaceuticals rose in post-market trading on Thursday after the company had a study protocol approved by regulators. The stock was up 7.8% to $9.10,. -January 04, 2024 at 06:39 pm EST
- MarketScreener
Fusion reported on Jan. 4 that it has completed validation of its good manufacturing practice (GMP) manufacturing facility and produced the first clinical dose of a TAT.